Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Francis

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Oncotarget|April 1, 2015
Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxyl-terminal deletion mutantsAngela K J Park, Joshua M Francis, Woong-Yang Park, et al.
Cancer Biology & Therapy|November 2, 2016
Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic isletsWenchu Lin, Joshua M Francis, Hong Li, et al.
Nature Genetics|December 15, 2015
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancersXiaoyang Zhang, Peter S Choi, Joshua M Francis, et al.
Nature|May 29, 2015
Chromothripsis from DNA damage in micronucleiCheng-Zhong Zhang, Alexander Spektor, Hauke Cornils, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2009
The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factorsOrit Rozenblatt-Rosen, Takashi Nagaike, Joshua M Francis, et al.
Molecular Cancer Research : MCR|December 25, 2014
Dynamic epigenetic regulation by menin during pancreatic islet tumor formationWenchu Lin, Hideo Watanabe, Shouyong Peng, et al.
Cancer Research|October 29, 2020
Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial CancersYanli Liu, Bingqian Guo, Estrella Aguilera-Jimenez, et al.
Neoplasia (New York, N.Y.)|July 11, 2021
Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapyAlycen P Lundberg, Matthew W Boudreau, Kim A Selting, et al.
Investigational New Drugs|December 16, 2016
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid speciesAlycen P Lundberg, Joshua M Francis, Malgorzata Pajak, et al.
Cancer Genetics|May 13, 2015
ARID1A and TERT promoter mutations in dedifferentiated meningiomaMalak S Abedalthagafi, Wenya Linda Bi, Parker H Merrill, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Oncotarget|April 1, 2015
Constitutive asymmetric dimerization drives oncogenic activation of epidermal growth factor receptor carboxyl-terminal deletion mutantsAngela K J Park, Joshua M Francis, Woong-Yang Park, et al.
Cancer Biology & Therapy|November 2, 2016
Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic isletsWenchu Lin, Joshua M Francis, Hong Li, et al.
Nature Genetics|December 15, 2015
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancersXiaoyang Zhang, Peter S Choi, Joshua M Francis, et al.
Nature|May 29, 2015
Chromothripsis from DNA damage in micronucleiCheng-Zhong Zhang, Alexander Spektor, Hauke Cornils, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2009
The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factorsOrit Rozenblatt-Rosen, Takashi Nagaike, Joshua M Francis, et al.
Molecular Cancer Research : MCR|December 25, 2014
Dynamic epigenetic regulation by menin during pancreatic islet tumor formationWenchu Lin, Hideo Watanabe, Shouyong Peng, et al.
Cancer Research|October 29, 2020
Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial CancersYanli Liu, Bingqian Guo, Estrella Aguilera-Jimenez, et al.
Neoplasia (New York, N.Y.)|July 11, 2021
Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapyAlycen P Lundberg, Matthew W Boudreau, Kim A Selting, et al.
Investigational New Drugs|December 16, 2016
Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid speciesAlycen P Lundberg, Joshua M Francis, Malgorzata Pajak, et al.
Cancer Genetics|May 13, 2015
ARID1A and TERT promoter mutations in dedifferentiated meningiomaMalak S Abedalthagafi, Wenya Linda Bi, Parker H Merrill, et al.
Pageof 3